Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma

Deku Liang,1,2 Min Hu,1 Qin Tang,1 Mao Huang,1 Liangdan Tang1 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Department of Obstetrics and Gynecology, Chengdu Women and Children’s Central Hospital Affili...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liang D, Hu M, Tang Q, Huang M, Tang L
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	endometrial carcinoma pyroptosis immunotherapy lncrnas immune infiltration Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/aba4c24e04c2496fa0a9fe3790e1ffcc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:aba4c24e04c2496fa0a9fe3790e1ffcc
record_format	dspace
spelling	oai:doaj.org-article:aba4c24e04c2496fa0a9fe3790e1ffcc2021-11-11T18:22:26ZNine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma1178-7074https://doaj.org/article/aba4c24e04c2496fa0a9fe3790e1ffcc2021-11-01T00:00:00Zhttps://www.dovepress.com/nine-pyroptosis-related-lncrnas-are-identified-as-biomarkers-for-predi-peer-reviewed-fulltext-article-IJGMhttps://doaj.org/toc/1178-7074Deku Liang,1,2 Min Hu,1 Qin Tang,1 Mao Huang,1 Liangdan Tang1 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Department of Obstetrics and Gynecology, Chengdu Women and Children’s Central Hospital Affiliated to University of Electronic Science and Technology of China, Chengdu, Sichuan Province, People’s Republic of ChinaCorrespondence: Liangdan Tang Email 201608@hospital.cqmu.edu.cnBackground: Endometrial carcinoma (EC) is one of the most common malignancies. Immunotherapy has shown promising effects in the treatment against specific subtypes of EC.Methods: The RNA and clinical information of patients with EC were acquired from The Cancer Gene Atlas (TCGA) database. Firstly, the differentially expressed pyroptosis-related lncRNAs (PRLs) were screened between the tumor and normal control tissue. Secondly, the PRLs closely related to survival were identified by univariate and multivariate regression analysis, based on which, we evaluated the risk score for each EC patient to construct a risk signature. Moreover, we assessed the prognostic value, clinical relevance immunity, and immunotherapy based on this signature.Results: We screened out 9 individual PRLs (AC087491.1, AL353622.1, AL035530.2, LINC02036, AL021578.1, AL390195.2, AC009097.2, AC004585.1, and AC244517.7) closely related to the prognosis of EC. Kaplan–Meier analyses showed a poorer prognosis for the patients in the high-risk FRLs signature (P < 0.001). The area under the curve (AUC) for 1 year, 2 years, 3 years was 0.693, 0.694, 0.750, respectively. Our risk model could be considered as an independent prognostic marker for EC (P < 0.001, HR:2.172, 95% CI:1.532– 3.079). Moreover, immune functions and checkpoints were generally different in the 2 groups. Simulation analysis by termed immunophenoscores hinted that immunotherapy might bring optimal therapeutic effect in the low-risk group.Conclusion: We successfully developed a novel signature with 9 lncRNAs related to pyroptosis, which may be used as biomarkers to evaluate the prognosis and immune treatment of EC.Keywords: endometrial carcinoma, pyroptosis, immunotherapy, lncRNAs, immune infiltrationLiang DHu MTang QHuang MTang LDove Medical Pressarticleendometrial carcinomapyroptosisimmunotherapylncrnasimmune infiltrationMedicine (General)R5-920ENInternational Journal of General Medicine, Vol Volume 14, Pp 8073-8085 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	endometrial carcinoma pyroptosis immunotherapy lncrnas immune infiltration Medicine (General) R5-920
spellingShingle	endometrial carcinoma pyroptosis immunotherapy lncrnas immune infiltration Medicine (General) R5-920 Liang D Hu M Tang Q Huang M Tang L Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
description	Deku Liang,1,2 Min Hu,1 Qin Tang,1 Mao Huang,1 Liangdan Tang1 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Department of Obstetrics and Gynecology, Chengdu Women and Children’s Central Hospital Affiliated to University of Electronic Science and Technology of China, Chengdu, Sichuan Province, People’s Republic of ChinaCorrespondence: Liangdan Tang Email 201608@hospital.cqmu.edu.cnBackground: Endometrial carcinoma (EC) is one of the most common malignancies. Immunotherapy has shown promising effects in the treatment against specific subtypes of EC.Methods: The RNA and clinical information of patients with EC were acquired from The Cancer Gene Atlas (TCGA) database. Firstly, the differentially expressed pyroptosis-related lncRNAs (PRLs) were screened between the tumor and normal control tissue. Secondly, the PRLs closely related to survival were identified by univariate and multivariate regression analysis, based on which, we evaluated the risk score for each EC patient to construct a risk signature. Moreover, we assessed the prognostic value, clinical relevance immunity, and immunotherapy based on this signature.Results: We screened out 9 individual PRLs (AC087491.1, AL353622.1, AL035530.2, LINC02036, AL021578.1, AL390195.2, AC009097.2, AC004585.1, and AC244517.7) closely related to the prognosis of EC. Kaplan–Meier analyses showed a poorer prognosis for the patients in the high-risk FRLs signature (P < 0.001). The area under the curve (AUC) for 1 year, 2 years, 3 years was 0.693, 0.694, 0.750, respectively. Our risk model could be considered as an independent prognostic marker for EC (P < 0.001, HR:2.172, 95% CI:1.532– 3.079). Moreover, immune functions and checkpoints were generally different in the 2 groups. Simulation analysis by termed immunophenoscores hinted that immunotherapy might bring optimal therapeutic effect in the low-risk group.Conclusion: We successfully developed a novel signature with 9 lncRNAs related to pyroptosis, which may be used as biomarkers to evaluate the prognosis and immune treatment of EC.Keywords: endometrial carcinoma, pyroptosis, immunotherapy, lncRNAs, immune infiltration
format	article
author	Liang D Hu M Tang Q Huang M Tang L
author_facet	Liang D Hu M Tang Q Huang M Tang L
author_sort	Liang D
title	Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
title_short	Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
title_full	Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
title_fullStr	Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
title_full_unstemmed	Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
title_sort	nine pyroptosis-related lncrnas are identified as biomarkers for predicting the prognosis and immunotherapy of endometrial carcinoma
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/aba4c24e04c2496fa0a9fe3790e1ffcc
work_keys_str_mv	AT liangd ninepyroptosisrelatedlncrnasareidentifiedasbiomarkersforpredictingtheprognosisandimmunotherapyofendometrialcarcinoma AT hum ninepyroptosisrelatedlncrnasareidentifiedasbiomarkersforpredictingtheprognosisandimmunotherapyofendometrialcarcinoma AT tangq ninepyroptosisrelatedlncrnasareidentifiedasbiomarkersforpredictingtheprognosisandimmunotherapyofendometrialcarcinoma AT huangm ninepyroptosisrelatedlncrnasareidentifiedasbiomarkersforpredictingtheprognosisandimmunotherapyofendometrialcarcinoma AT tangl ninepyroptosisrelatedlncrnasareidentifiedasbiomarkersforpredictingtheprognosisandimmunotherapyofendometrialcarcinoma
_version_	1718431843763617792

Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma

Ejemplares similares